Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688013's EV-to-EBIT is ranked worse than 71.1% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 18.005
vs SHSE:688013: 29.06
Touchstone International Medical Science Co (SHSE:688013) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Touchstone International Medical Science Co's Enterprise Value for the quarter that ended in Jun. 2026 was ¥1,881.0 Mil.
Touchstone International Medical Science Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥58.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co EV-to-EBIT Related Terms
Touchstone International Medical Science Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co EV-to-EBIT Chart
Touchstone International Medical Science Co Annual Data
SHSE:688013 vs ISRG, BDX, RMD: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touchstone International Medical Science Co EV-to-EBIT vs Medical Devices & Instruments Industry
Touchstone International Medical Science Co's current Enterprise Value is ¥1,690.3 Mil.
Touchstone International Medical Science Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥58.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co (SHSE:688013) has a EV-to-EBIT of 29.06 as of Sep. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Touchstone International Medical Science Co and its competitors. This is 14% below median its historical median of 33.84. Over the past decade, Touchstone International Medical Science Co's EV-to-EBIT has ranged from 13.84 to 68.54. According to the industry distribution chart, Touchstone International Medical Science Co ranks #337 out of 474 companies in the Medical Devices & Instruments industry, placing it in the top 71.1%.
Is Touchstone International Medical Science Co's EV-to-EBIT too high?
Touchstone International Medical Science Co's current EV-to-EBIT of 29.06 is 14% below median its 10-year median of 33.84. Over the past 10 years, this metric has ranged from a low of 13.84 to a high of 68.54. The Medical Devices & Instruments industry median EV-to-EBIT is 18.01. Touchstone International Medical Science Co's value of 29.06 is 61.4% above this industry median. Based on the distribution chart, Touchstone International Medical Science Co ranks #337 out of 474 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Touchstone International Medical Science Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Touchstone International Medical Science Co ranks #337 out of 474 companies for EV-to-EBIT. This places Touchstone International Medical Science Co in the lower half of its industry. The industry median EV-to-EBIT is 18.01. Touchstone International Medical Science Co's value of 29.06 is 61.4% above this benchmark. Historically, Touchstone International Medical Science Co's own EV-to-EBIT has ranged from 13.84 to 68.54 over the past decade. While the company's 10-year median is 33.84 vs. the industry median of 18.01, Touchstone International Medical Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.01, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touchstone International Medical Science Co's current EV-to-EBIT of 29.06 is 61.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current EV-to-EBIT is 29.06, which is 14% below median its own 10-year median of 33.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.35, compared to a current price of ¥22.32 — trading 8.3% below its estimated fair value. The current EV-to-EBIT is 29.06, which is 14% below median its 10-year median of 33.84 and 61.4% above the Medical Devices & Instruments industry median of 18.01. Touchstone International Medical Science Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current EV-to-EBIT is 29.06 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?
Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued.
The current stock price of ¥22.32 is trading 8.3% below its estimated GF Value™ of ¥24.35.
GuruFocus considers Touchstone International Medical Science Co to be Fairly Valued.
Key valuation signals for SHSE:688013:
EV-to-EBIT: 29.06 (14% below median its 10-year median of 33.84)
GF Value™: ¥24.35 vs. price of ¥22.32 (8.3% below fair value)
Industry Position: 61.4% above the Medical Devices & Instruments median (#337 of 474)
No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
79GF Score
Get the complete analysis for SHSE:688013
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688013 has been successfully added to your 
